EUCTR2004-002855-15-IT
进行中（未招募）
不适用
A long term extension to a randomised, double-blind, placebo-controlled, stratified, paralle-group, multicenter, dose-ranging study evaluating four oral doses of TCH346 1.0, 2.5, 7.5 and 15 mg administered once daily in patients with Amyotrophic Lateral Sclerosis
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Amyotrophic Lateral Sclerosis
- 发起方
- OVARTIS FARMA
- 入组人数
- 476
- 状态
- 进行中（未招募）
- 最后更新
- 14年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
排除标准
- 未提供
结局指标
主要结局
未指定
相似试验
进行中（未招募）
不适用
A long-term extension to a randomized, double-blind, placebo-controlled, stratified, parallel-group, multicenter, dose-ranging study evaluating four oral doses of TCH346 (1.0, 2.5, 7.5 and 15mg) administered once daily in patients with Amyotrophic Lateral Sclerosis.Amyotrophic Lateral SclerosisEUCTR2004-002855-15-DEovartis Pharma Services AG480
进行中（未招募）
不适用
A long-term extension to a randomized, double-blind, placebo-controlled, stratified, parallel-group, multicenter, dose-ranging study evaluating four oral doses of TCH346 (1.0, 2.5, 7.5 and 15mg) administered once daily in patients with Amyotrophic Lateral Sclerosis.Amyotrophic Lateral SclerosisEUCTR2004-002855-15-GBovartis Pharma Services AG480
进行中（未招募）
3 期
REVEAL 1 (Randomized Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)Cervical DysplasiaCervical High Grade Squamous Intraepithelial LesionHSITCTR20170301001Inovio Pharmaceuticals, Inc.201
进行中（未招募）
不适用
A LONG-TERM, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP,PLACEBO-CONTROLLED, RADIOGRAPHIC STUDY TO INVESTIGATE THESAFETY AND EFFICACY OF ORALLY ADMINISTERED SD-6010 IN SUBJECTSWITH SYMPTOMATIC OSTEOARTHRITIS OF THE KNEEEUCTR2007-001457-26-CZPfizer Inc, 235 East 42nd Street, New York, NY 100171,400
进行中（未招募）
不适用
A LONG-TERM, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, RADIOGRAPHIC STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF ORALLY ADMINISTERED SD-6010 IN SUBJECTS WITH SYMPTOMATIC OSTEOARTHRITIS OF THE KNEE - NDEUCTR2007-001457-26-ITPFIZER1,400